NDAQ:VMD - Post Discussion
Post by
lscfa on Mar 09, 2024 11:01am
Lake Street tp $15
TipRanks
Mar. 7, 2024, 07:50 AM There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Viemed Healthcare (VMD – Research Report) and Aquestive Therapeutics (AQST – Research Report) with bullish sentiments.
Viemed Healthcare (VMD)
In a report released today, Brooks O’Neil from Lake Street maintained a Buy rating on Viemed Healthcare, with a price target of $15.00. The company’s shares closed last Wednesday at $9.38.
According to TipRanks.com, O’Neil is a 3-star analyst with an average return of 1.0% and a 46.8% success rate. O’Neil covers the Healthcare sector, focusing on stocks such as Streamline Health Solutions, Tandem Diabetes Care, and Alphatec Holdings.
Currently, the analyst consensus on Viemed Healthcare is a Moderate Buy with an average price target of $15.00.
Be the first to comment on this post